Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: DIGENIS who wrote (1311)	3/17/1998 6:12:00 PM
From: DRRISK	Read Replies (2) \| Respond to of 2068

Digenis, The stock traded down today but had a lot of support at the 16 3/8 level and established a very narrow range after a sell off in AM on low volume. We need visibility and that will make all the difference. IMHO. I agree that purchases at this level are probably safe as can be on a speculative low visibility company that has tremendous institutional following. A company with the problems that OXHP has can become a darling again if management takes decisive control. This could change the sentiment overnight. The reason is that the market will look for safe havens now and OXHP could position itself as a turn around story if Payson et al can give cofidence to their direction, any ambivalence will be severely punished. Any percieved deception will be deadly to ongoing shareholder value. The good part is that everyone is aligned for rewards based on stock appreciation. That always gives me confidence as an investor. DrRisk